《Nature,12月30日,Hydrogel particles improve detection of SARS-CoV-2 RNA from multiple sample types》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2021-02-03
  • Hydrogel particles improve detection of SARS-CoV-2 RNA from multiple sample types
    R. A. Barclay, I. Akhrymuk, A. Patnaik, V. Callahan, C. Lehman, P. Andersen, R. Barbero, S. Barksdale, R. Dunlap, D. Goldfarb, T. Jones-Roe, R. Kelly, B. Kim, S. Miao, A. Munns, D. Munns, S. Patel, E. Porter, R. Ramsey, S. Sahoo, O. Swahn, J. Warsh, K. Kehn-Hall & B. Lepene
    Scientific Reports volume 10, Article number: 22425 (2020)

    Abstract
    Here we present a rapid and versatile method for capturing and concentrating SARS-CoV-2 from contrived transport medium and saliva samples using affinity-capture magnetic hydrogel particles. We demonstrate that the method concentrates virus from 1 mL samples prior to RNA extraction, substantially improving detection of virus using real-time RT-PCR across a range of viral titers (100–1,000,000 viral copies/mL) and enabling detection of virus using the 2019 nCoV CDC EUA Kit down to 100 viral copies/mL. This method is compatible with commercially available nucleic acid extraction kits (i.e., from Qiagen) and a simple heat and detergent method that extracts viral RNA directly off the particle, allowing a sample processing time of 10 min. We furthermore tested our method in transport medium diagnostic remnant samples that previously had been tested for SARS-CoV-2, showing that our method not only correctly identified all positive samples but also substantially improved detection of the virus in low viral load samples. The average improvement in cycle threshold value across all viral titers tested was 3.1. Finally, we illustrate that our method could potentially be used to enable pooled testing, as we observed considerable improvement in the detection of SARS-CoV-2 RNA from sample volumes of up to 10 mL.

  • 原文来源:https://www.nature.com/articles/s41598-020-78771-8
相关报告
  • 《Nature,4月16日,CRISPR–Cas12-based detection of SARS-CoV-2》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-04-17
    • CRISPR–Cas12-based detection of SARS-CoV-2 James P. Broughton, Xianding Deng, Guixia Yu, Clare L. Fasching, Venice Servellita, Jasmeet Singh, Xin Miao, Jessica A. Streithorst, Andrea Granados, Alicia Sotomayor-Gonzalez, Kelsey Zorn, Allan Gopez, Elaine Hsu, Wei Gu, Steve Miller, Chao-Yang Pan, Hugo Guevara, Debra A. Wadford, Janice S. Chen & Charles Y. Chiu Nature Biotechnology (2020) Abstract An outbreak of betacoronavirus severe acute respiratory syndrome (SARS)-CoV-2 began in Wuhan, China in December 2019. COVID-19, the disease associated with SARS-CoV-2 infection, rapidly spread to produce a global pandemic. We report development of a rapid (<40 min), easy-to-implement and accurate CRISPR–Cas12-based lateral flow assay for detection of SARS-CoV-2 from respiratory swab RNA extracts. We validated our method using contrived reference samples and clinical samples from patients in the United States, including 36 patients with COVID-19 infection and 42 patients with other viral respiratory infections.
  • 《Virus Evolution,4月30日,No evidence for distinct types in the evolution of SARS-CoV-2》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-05-02
    • No evidence for distinct types in the evolution of SARS-CoV-2 Oscar A MacLean, Richard J Orton, Joshua B Singer, David L Robertson Virus Evolution, veaa034, https://doi.org/10.1093/ve/veaa034 Published: 30 April 2020 Article history Abstract A recent study by Tang et al. (2020) claimed that two major types of SARS-CoV-2 had evolved in the ongoing COVID-19 pandemic and that one of these types was more “aggressive” than the other. Given the repercussions of these claims and the intense media coverage of these types of articles, we have examined in detail the data presented by Tang et al, and show that the major conclusions of that paper cannot be substantiated. Using examples from other viral outbreaks we discuss the difficulty in demonstrating the existence or nature of a functional effect of a viral mutation, and we advise against overinterpretation of genomic data during the pandemic.